Lacosamide 69367-0352
Product NDC
69367-0352- Manufacturer
- Westminster Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- May 23, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA218706
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
10 VIAL, GLASS in 1 CARTON (69367-352-10) / 20 mL in 1 VIAL, GLASS (69367-352-20)